About 1 in 8 adults in the United States has used a GLP-1 drug like Ozempic or Mounjaro at some point in their life.
A poll from the health policy nonprofit KFF found that 1 in 8 adults say they’ve taken a GLP-1 agonist, the obesity and ...
The data also showed that 6% of those polled said they were currently using a GLP-1 drug, such as Novo Nordisk's diabetes ...
The majority — 62 percent — said they were using the drugs to treat a chronic condition like diabetes or heart disease while ...
About 12% of American adults say they have used one of the increasingly popular weight loss and diabetes drugs known as GLP-1s, and 6% say they are currently taking such a drug, according to a new ...
About 1 in 8 adults in the United States has used a GLP-1 drug like Ozempic or Mounjaro at some point in their life, and half of them – about 6% of adults, or more than 15 million people – are ...
I’M MINDY BASARA IN TODAY’S MEDICAL ALERT, WEIGHT LOSS AND DIABETES DRUGS LIKE OZEMPIC WEGOVY AND ZYBAN ARE ALL THE RAGE RIGHT NOW. AND TO HELP BETTER UNDERSTAND WHAT’S HAPPENING WITH THESE ...